Diagnostics & Research
The Diagnostics & Research industry has a total of 51 stocks, with a combined market cap of $613.23 billion, total revenue of $161.64 billion and a weighted average PE ratio of 50.35.
Market Cap
613.23B
Revenue
161.64B
Profits
12.18B
PE Ratio
50.35
Profit Margin
7.54%
Dividend Yield
0.31%
51 Stocks
No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
---|---|---|---|---|---|---|
1 | TMO | Thermo Fisher Scientific Inc. | 162.42B | 6.73% | 2,691,100 | 42.90B |
2 | DHR | Danaher Corporation | 142.82B | 5.18% | 5,551,487 | 23.82B |
3 | IDXX | IDEXX Laboratories, Inc. | 40.88B | 3.39% | 466,519 | 3.93B |
4 | A | Agilent Technologies, Inc. | 32.80B | 7.60% | 1,957,931 | 6.53B |
5 | IQV | IQVIA Holdings Inc. | 26.88B | 4.27% | 4,258,485 | 15.50B |
6 | MTD | Mettler-Toledo International Inc. | 24.33B | 8.31% | 143,090 | 3.83B |
7 | WAT | Waters Corporation | 21.78B | 6.38% | 334,258 | 2.98B |
8 | NTRA | Natera, Inc. | 21.28B | 2.56% | 1,437,503 | 1.83B |
9 | LH | Labcorp Holdings Inc. | 20.94B | 1.83% | 596,718 | 13.18B |
10 | DGX | Quest Diagnostics Incorporated | 19.62B | -0.67% | 830,426 | 10.16B |
11 | ILMN | Illumina, Inc. | 12.86B | 7.26% | 2,422,158 | 4.34B |
12 | RVTY | Revvity, Inc. | 11.58B | 7.65% | 1,032,722 | 2.77B |
13 | ICLR | ICON Public Limited Company | 11.24B | 5.55% | 843,718 | 8.19B |
14 | EXAS | Exact Sciences Corporation | 10.05B | 3.16% | 1,073,451 | 2.83B |
15 | QGEN | Qiagen N.V. | 9.24B | 1.94% | 1,040,093 | 2.00B |
16 | MEDP | Medpace Holdings, Inc. | 9.01B | 5.86% | 245,983 | 2.16B |
17 | CRL | Charles River Laboratories International, Inc. | 7.06B | 3.62% | 1,321,663 | 4.02B |
18 | GH | Guardant Health, Inc. | 5.14B | -0.60% | 1,505,555 | 774.00M |
19 | RDNT | RadNet, Inc. | 4.28B | 2.26% | 743,437 | 1.87B |
20 | SHC | Sotera Health Company | 3.82B | 2.44% | 636,025 | 1.11B |
21 | VCYT | Veracyte, Inc. | 2.42B | 4.11% | 610,219 | 463.39M |
22 | TWST | Twist Bioscience Corporation | 1.98B | 7.14% | 741,957 | 347.68M |
23 | WGS | GeneDx Holdings Corp. | 1.69B | 0.44% | 938,726 | 330.14M |
24 | NEOG | Neogen Corporation | 1.41B | 8.63% | 5,395,183 | 906.00M |
25 | GRAL | GRAIL, Inc. | 1.26B | 1.70% | 647,942 | 125.60M |
26 | NEO | NeoGenomics, Inc. | 1.08B | 4.47% | 1,104,764 | 672.36M |
27 | OPK | OPKO Health, Inc. | 1.01B | 2.82% | 2,137,206 | 689.41M |
28 | CDNA | CareDx, Inc | 909.26M | 6.32% | 1,120,067 | 346.42M |
29 | FLGT | Fulgent Genetics, Inc. | 613.13M | 2.23% | 269,395 | 292.45M |
30 | CSTL | Castle Biosciences, Inc. | 492.27M | 1.58% | 226,610 | 347.08M |
31 | PSNL | Personalis, Inc. | 448.38M | 0.79% | 528,677 | 85.69M |
32 | MYGN | Myriad Genetics, Inc. | 387.15M | 7.97% | 2,415,961 | 831.30M |
33 | ATLN | Atlantic International Corp. | 186.62M | - | 13,862 | 442.61M |
34 | XGN | Exagen Inc. | 104.05M | 1.23% | 178,868 | 56.72M |
35 | MDXH | MDxHealth SA | 89.10M | -3.74% | 87,481 | 90.05M |
36 | FONR | FONAR Corporation | 79.46M | 1.29% | 7,598 | 101.57M |
37 | OCX | OncoCyte Corporation | 78.65M | -4.18% | 59,965 | 1.88M |
38 | NOTV | Inotiv, Inc. | 73.84M | 11.22% | 369,094 | 480.40M |
39 | PRE | Prenetics Global Limited | 68.30M | -2.74% | 7,592 | 30.62M |
40 | BDSX | Biodesix, Inc. | 54.49M | 0.46% | 1,049,667 | 71.32M |
41 | BNR | Burning Rock Biotech Limited | 27.24M | 8.81% | 9,345 | 70.67M |
42 | PRPH | ProPhase Labs, Inc. | 13.82M | 8.88% | 522,430 | 6.77M |
43 | PRPO | Precipio, Inc. | 9.45M | -5.19% | 2,586 | 18.53M |
44 | STRR | Star Equity Holdings, Inc. | 7.82M | -1.20% | 13,263 | 53.36M |
45 | MYNZ | Mainz Biomed N.V. | 7.66M | 2.86% | 128,275 | 893.99K |
46 | APDN | Applied DNA Sciences, Inc. | 5.39M | 1.10% | 367,888 | 3.74M |
47 | CHEK | Check-Cap Ltd. | 4.76M | -0.65% | 124,119 | - |
48 | XWEL | XWELL, Inc. | 4.47M | -3.42% | 277,148 | 33.90M |
49 | BIAF | bioAffinity Technologies, Inc. | 3.53M | -4.42% | 699,088 | 9.36M |
50 | ISPC | iSpecimen Inc. | 2.93M | 3.26% | 18,909 | 9.29M |
51 | NDRA | ENDRA Life Sciences Inc. | 1.89M | 3.37% | 122,558 | - |